Drug prices in France: Summary of the recent developments in the French pricing system
Type de matériel :
TexteLangue : français Détails de publication : 2018.
Ressources en ligne : Abrégé : This article presents the different aspects of determining the price of reimbursable medicines in France. We discuss how drug prices are set according to drug status : in commercial distribution (brand-name and generic drugs) and in hospital distribution ( liste de retrocession [retrocession list] and liste en sus [supplementary list]). Pricing issues and other recent developments are discussed, as well as the role of relevant institutions such as the Healthcare Products Pricing Committee (CEPS) and the French National Authority for Health (HAS).
Nous n'avons pas d'exemplaire de ce document
46
This article presents the different aspects of determining the price of reimbursable medicines in France. We discuss how drug prices are set according to drug status : in commercial distribution (brand-name and generic drugs) and in hospital distribution ( liste de retrocession [retrocession list] and liste en sus [supplementary list]). Pricing issues and other recent developments are discussed, as well as the role of relevant institutions such as the Healthcare Products Pricing Committee (CEPS) and the French National Authority for Health (HAS).
Réseaux sociaux